25% Tilmicosin Oral Solution yehuku
.png)
.png)
.png)
.png)
Composition
100ml ine 25g Tilmicosin.
Pharmacological chiito
Pharmacodynamics Teicoplanin inonzi semisynthetic macrolide antibiotic yakatsaurirwa kumhuka.Kune mycoplasma, iyo inorwisa mabhakitiriya yakafanana neiyo yetylosin, uye mabhakitiriya ane giremu ane giremu ari Staphylococcus aureus (kusanganisira penicillin-resistant Staphylococcus aureus), pneumococcus, streptococcus, Bacillus anthracis, Erysipelothrix, Portococcus, Erysipelothrix, Portococcus aureus emphysematosus.Sensitive gram-negative mabhakitiriya anosanganisira Haemophilus, meningococcus uye Pasteurella.Inonyanya kushanda kupfuura tylosin kurwisa Actinobacillus pleuropneumoniae, Pasteurella uye Mycoplasma bovis.Makumi mapfumbamwe neshanu muzana ePasteurella haemolytica strains anotapukirwa nechigadzirwa ichi.
Pharmacokinetics
Mhinduro yeTilmicosin inokurumidza kubatwa mushure mekutonga kwemuromo uye inoratidzirwa nekupinza kwenyama yakasimba uye yakakura yakawanda yekugovera (yakakura kupfuura 2 L / kg).Iko kusungirirwa mumapapu kwakakwirira, kubviswa kwehafu yehupenyu kunogona kusvika 1 kusvika kumazuva maviri, uye iyo inoshanda yeplasma concentration inochengetwa kwenguva yakareba.
Kudyidzana kwezvinodhaka
(1) Tilmicosin ine chinangwa chakafanana nemamwe macrolides uye lincosamines uye haifaniri kushandiswa panguva imwe chete.
(2) kusanganiswa ne β-lactam kwakaratidza kupesana.
Kubvisa Nguva
27days vasati vauraya.
Kwete yekushandiswa mumombe dzemukaka dzezera rekubereka, kana mune chero mombe mukati memazuva makumi mana ekutanga ekuzvitakura (kana mazuva ekutanga 45 mushure mekubvisa nzombe)
Chiito uye kushandiswa
Macrolide antibiotics.Inoshandiswa kurapa huku zvirwere zvekufema zvinokonzerwa nePasteurella uye Mycoplasma.
Dosage uye kutonga
Chinwiwa chakasanganiswa: 0.3 ml pa 1 L yemvura yehuku.Kwemazuva matatu.
Maitiro asina kunaka
Muchetura wechigadzirwa ichi pamhuka unonyanya kukonzeresa tachycardia uye kuderera kwechibvumirano.
Zvekungwaririra
Tilmicosin oral solution inopikiswa mukukandira huku panguva yekukandira.
Withdrawal Period
Huku kwemazuva gumi nemaviri.
Storage
Chengetedza mumamiriro akavharwa, akachengetedzwa kubva kuchiedza.
Hebei Veyong Pharmaceutical Co., Ltd, yakavambwa muna 2002, iri muShijiazhuang City, Hebei Province, China, padyo neguta guru Beijing.Iye ihombe GMP-yakasimbiswa veterinary drug bhizinesi, ine R&D, kugadzira uye kutengesa kweVeterinary APIs, gadziriro, premixed feed uye feed additives.SeProvincial Technical Center, Veyong yakamisa hurongwa hweR&D hwemishonga mitsva yezvipfuyo, uye ndiyo inozivikanwa pasi rose tekinoroji innovation yakavakirwa bhizinesi rezvipfuyo, kune makumi matanhatu neshanu nyanzvi.Veyong ine mabhesi maviri ekugadzira: Shijiazhuang neOrdos, iyo iyo Shijiazhuang base inovhara nzvimbo ye78,706 m2, ine 13 API zvigadzirwa zvinosanganisira Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, uye 11, gadziriro yekugadzira oral poda, mitsara yekugadzira oral. , premix, bolus, mishonga yezvipembenene nemishonga inouraya utachiona, ects.Veyong inopa APIs, anopfuura zana ega- label gadziriro, uye OEM & ODM sevhisi.
Veyong inokoshesa zvikuru manejimendi eEHS(Environment, Health & Safety) system, uye yakawana ISO14001 uye OHSAS18001 zvitupa.Veyong yakanyorwa mumabhizinesi ari kusimukira maindasitiri muHebei Province uye inogona kuve nechokwadi chekuenderera mberi kwezvigadzirwa.
Veyong yakamisa hurongwa hwekutonga kwemhando yakakwana, yakawana chitupa cheISO9001, chitupa cheChina GMP, chitupa cheAustralia APVMA GMP, chitupa cheEthiopia GMP, chitupa cheIvermectin CEP, uye yakapasa ongororo yeUS FDA.Veyong ine timu yehunyanzvi yekunyoresa, kutengesa uye tekinoroji sevhisi, kambani yedu yakawana kuvimba nerutsigiro kubva kune akawanda vatengi nemhando yepamusoro yechigadzirwa, yepamusoro-yemhando yepamusoro-yekutanga kutengesa uye mushure mekutengesa sevhisi, yakakomba uye yesainzi manejimendi.Veyong yaita kushandira pamwe kwenguva refu nemabhizinesi mazhinji anozivikanwa pasi rose emishonga yemhuka ane zvigadzirwa zvinotengeswa kuEurope, South America, Middle East, Africa, Asia, etc. kupfuura nyika makumi matanhatu nematunhu.
